T1	Eq-Comparison 31 54	between the ages of 18-
E1	Eq-Comparison:T1 Value:T39 Operator:T40
T2	Study 103 108	study
E2	Study:T2 
T3	Condition 114 132	Spastic Hemiplegia
E3	Condition:T3 Name:T42
T4	Observation 134 157	Modified Ashworth Scale
E4	Observation:T4 Name:T43
T5	Eq-Comparison 158 169	2 and above
E5	Eq-Comparison:T5 Value:T44 Operator:T45
T6	Condition 196 204	Pregnant
E6	Condition:T6 Name:T46
T7	Condition 212 225	breastfeeding
E7	Condition:T7 Name:T48
T8	And 226 229	and
E8	And:T8 
T9	Eq-Comparison 230 251	younger than 18 years
E9	Eq-Comparison:T9 Operator:T49 Value:T50 Temporal-Unit:T51
T10	Drug 265 275	medication
E10	Drug:T10 
T11	And 276 279	and
E11	And:T11 
T12	Condition 280 293	substance use
E12	Condition:T12 
T13	Condition 302 312	neuropathy
E13	Condition:T13 Name:T52
T14	Eq-Comparison 320 327	history
E14	Eq-Comparison:T14 Temporal-Period:T53
T15	Condition 335 342	disease
E15	Condition:T15 
T16	Or 343 348	and /
E16	Or:T16 
T17	Or 349 351	or
E17	Or:T17 
T18	Condition 352 362	neuropathy
E18	Condition:T18 Name:T55
T19	Eq-Comparison 388 396	received
E19	Eq-Comparison:T19 Temporal-Period:T56
T20	Procedure 397 430	botulinum toxin injection therapy
E20	Procedure:T20 Name:T57
T21	And 431 434	and
E21	And:T21 
T22	Or 435 436	/
E22	Or:T22 
T23	Or 437 439	or
E23	Or:T23 
T24	Modifier 440 444	oral
E24	Modifier:T24 
T25	Procedure 445 464	antispastic therapy
E25	Procedure:T25 
T26	Eq-Comparison 465 489	within the last 6 months
E26	Eq-Comparison:T26 Operator:T59 Temporal-Period:T60 Value:T61 Temporal-Unit:T62
T27	Eq-Comparison 502 509	history
E27	Eq-Comparison:T27 Temporal-Period:T63
T28	Allergy 513 522	allergies
E28	Allergy:T28 
T29	Or 523 526	and
E29	Or:T29 
T30	Condition 527 543	hypersensitivity
E30	Condition:T30 Name:T64
T31	Drug 557 561	drug
E31	Drug:T31 
T32	Procedure 577 586	treatment
E32	Procedure:T32 
T33	Eq-Comparison 587 594	planned
E33	Eq-Comparison:T33 Temporal-Period:T65
T34	Procedure 595 616	purification hematoma
E34	Procedure:T34 Name:T66
T35	Modifier 618 626	cleaning
E35	Modifier:T35 
T36	Or 627 629	or
E36	Or:T36 
T37	Modifier 630 634	skin
E37	Modifier:T37 
T38	Condition 635 641	lesion
E38	Condition:T38 Name:T67
T39	Eq-Value 51 53	18
T40	Eq-Operator 53 54	-
A1	Eq-Operator-Value T40 BETWEEN
T41	Eq-Value 54 56	60
T42	Condition-Name 114 132	Spastic Hemiplegia
T43	Observation-Name 134 157	Modified Ashworth Scale
A2	Observation-Type-Value T43 clinical-score
T44	Eq-Value 158 159	2
T45	Eq-Operator 160 169	and above
A3	Eq-Operator-Value T45 GTEQ
T46	Condition-Name 196 204	Pregnant
T47	Life-Stage-And-Gender 205 210	women
A4	Life-Stage-And-Gender-Type T47 female
T48	Condition-Name 212 225	breastfeeding
T49	Eq-Operator 230 242	younger than
A5	Eq-Operator-Value T49 LT
T50	Eq-Value 243 245	18
T51	Eq-Temporal-Unit 246 251	years
A6	Eq-Temporal-Unit-Value T51 year
T52	Condition-Name 302 312	neuropathy
T53	Eq-Temporal-Period 320 327	history
A7	Eq-Temporal-Period-Value T53 past
T54	Condition-Name 328 342	of the disease
T55	Condition-Name 352 362	neuropathy
T56	Eq-Temporal-Period 388 396	received
A8	Eq-Temporal-Period-Value T56 past
T57	Procedure-Name 397 430	botulinum toxin injection therapy
T58	Drug-Name 440 464	oral antispastic therapy
T59	Eq-Operator 465 471	within
A9	Eq-Operator-Value T59 LTEQ
T60	Eq-Temporal-Period 476 480	last
A10	Eq-Temporal-Period-Value T60 past
T61	Eq-Value 481 482	6
T62	Eq-Temporal-Unit 483 489	months
A11	Eq-Temporal-Unit-Value T62 month
T63	Eq-Temporal-Period 502 509	history
A12	Eq-Temporal-Period-Value T63 past
T64	Condition-Name 527 543	hypersensitivity
T65	Eq-Temporal-Period 587 594	planned
A13	Eq-Temporal-Period-Value T65 future
T66	Procedure-Name 595 616	purification hematoma
T67	Condition-Name 635 641	lesion
